Neuropathologic diagnostics was performed in concordance with the WHO classification from 2016 [9 (link)]. The following molecular data were obtained as part of daily routine: IDH mutation status was obtained by immunohistochemistry or direct sequencing of the mutation hotspot region for all patients [16 (link)]. 1p/19q codeletion status was available for all patients. Genome wide methylation analysis with copy number analysis was available for 171 patients (83%) and was generated using the Illumina HumanMethylation450 (450 k) or Methylation EPIC (850 k) array platforms as described [17 (link)].
Free full text: Click here